3,6-dimethylaminodibenzopyriodonium citrate has been researched along with Myocardial Ischemia in 1 studies
*Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SY; Deng, XL; Liu, JT; Qiu, PL | 1 |
1 other study(ies) available for 3,6-dimethylaminodibenzopyriodonium citrate and Myocardial Ischemia
| Article | Year |
|---|---|
[Protective effects of 3, 6-dimethamidodibenzopyriodinium citrate on myocardial injury induced by ischemia and reperfusion in rats].
Topics: Animals; Calcium; Calcium Channel Blockers; Creatine Kinase; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Onium Compounds; Rats; Rats, Sprague-Dawley | 1993 |